Bhakti Agung Propertindo Tbk. vs Merck Tbk. — how do they compare? Bhakti Agung Propertindo Tbk. trades at Rp16 (market cap 83.88B, 40.36M 24h volume), while Merck Tbk. trades at Rp3,740 (market cap 1.68T, 22.8K 24h volume). The key difference: Merck Tbk. is far larger — about 20× Bhakti Agung Propertindo Tbk.'s market cap, and Bhakti Agung Propertindo Tbk. is more actively traded (40.36M versus 22.8K). Which is the better fit depends on your goals.
| BAPI | MERK | |
|---|---|---|
Market Cap | 83.88B | 1.68T |
Volume | 40.36M | 22.8K |
Lot | 403.57K | 228 |
Turnover | 645.71M | 82.9M |
Average Price | 16 | 3,636.14 |
Value | 645.71M | 82.9M |
Indicative Equilibrium Price | 16 | 3,520 |
Indicative Equilibrium Volume | 103.93K | 60 |
Trailing returns across standard periods
Latest headlines on both assets
PT Bhakti Agung Propertindo Tbk (the “Company”) was established in the Republic of Indonesia originally under the name of “PT Paku Bumi Sejahtera” on July 20, 2012 based on Notarial Deed No. 3 of Habib, S.H., M.Hum.
Read more on BAPI →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →